178 related articles for article (PubMed ID: 37518985)
1. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
[TBL] [Abstract][Full Text] [Related]
2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
3. PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.
Ponente M; Campanini L; Cuttano R; Piunti A; Delledonne GA; Coltella N; Valsecchi R; Villa A; Cavallaro U; Pattini L; Doglioni C; Bernardi R
JCI Insight; 2017 Feb; 2(4):e87380. PubMed ID: 28239645
[TBL] [Abstract][Full Text] [Related]
4. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
6. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
[TBL] [Abstract][Full Text] [Related]
7. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
Lee Y; Jung WH; Koo JS
Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors.
Sachini N; Arampatzi P; Klonizakis A; Nikolaou C; Makatounakis T; Lam EW; Kretsovali A; Papamatheakis J
Mol Oncol; 2019 Jun; 13(6):1369-1387. PubMed ID: 30927552
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
Do HTT; Cho J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
[TBL] [Abstract][Full Text] [Related]
11. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
12. Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (PML).
Di Biase A; Miles AK; Regad T
Methods Mol Biol; 2018; 1692():129-138. PubMed ID: 28986893
[TBL] [Abstract][Full Text] [Related]
13. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic leukemia protein (PML) and stem cells: from cancer to pluripotency.
Vogiatzoglou AP; Moretto F; Makkou M; Papamatheakis J; Kretsovali A
Int J Dev Biol; 2022; 66(1-2-3):85-95. PubMed ID: 34881785
[TBL] [Abstract][Full Text] [Related]
15. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
[TBL] [Abstract][Full Text] [Related]
16. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
[TBL] [Abstract][Full Text] [Related]
17. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.
Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J
BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
19. TP53I11 suppresses epithelial-mesenchymal transition and metastasis of breast cancer cells.
Xiao T; Xu Z; Zhang H; Geng J; Qiao Y; Liang Y; Yu Y; Dong Q; Suo G
BMB Rep; 2019 Jun; 52(6):379-384. PubMed ID: 30940320
[TBL] [Abstract][Full Text] [Related]
20. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.
Reineke EL; Lam M; Liu Q; Liu Y; Stanya KJ; Chang KS; Means AR; Kao HY
Mol Cell Biol; 2008 Feb; 28(3):997-1006. PubMed ID: 18039859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]